by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a recent study, researchers at Hoag Family Cancer Institute found that a novel imaging technique targeting estrogen receptor (ER) performs on par with current standard-of-care methods for staging locally advanced breast cancer and detecting recurrence.1 The findings of the study suggest that 16α-18F-fluoro-17β-estradiol (FES) positron emission tomography/computed tomography (PET/CT) could be a valuable tool […]
Source